{{Rsnum
|rsid=10518025
|Chromosome=4
|position=67198722
|Orientation=plus
|GMAF=0.135
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 20.4 | 77.9
| HCB | 0.0 | 21.3 | 78.7
| JPT | 5.3 | 11.5 | 83.2
| YRI | 2.8 | 25.5 | 71.7
| ASW | 5.3 | 28.1 | 66.7
| CHB | 0.0 | 21.3 | 78.7
| CHD | 0.0 | 10.1 | 89.9
| GIH | 1.0 | 25.7 | 73.3
| LWK | 2.7 | 25.5 | 71.8
| MEX | 5.2 | 27.6 | 67.2
| MKK | 7.7 | 39.1 | 53.2
| TSI | 0.0 | 12.7 | 87.3
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000004
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs10518025
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 4q13.2; Reported Gene(s): CENPC1; Risk Allele: rs10518025-?); (p-value= 0.000004).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740729
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10518025
|overall_frequency_n=19
|overall_frequency_d=128
|overall_frequency=0.148438
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=14
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}